System and method for tumor characterization

US12019674B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12019674-B2
Application numberUS-202016887036-A
CountryUS
Kind codeB2
Filing dateMay 29, 2020
Priority dateMay 29, 2019
Publication dateJun 25, 2024
Grant dateJun 25, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of treating a subject comprises administering a treatment to a subject identified as having a high probability of distant metastatic recurrence, wherein the probability of distant metastatic recurrence was determined by a process, comprising acquiring at least one image of a tissue sample comprising a plurality of cells, taken from a subject, classifying each of the plurality of cells into categories, dividing the at least one image into a plurality of patches, calculating values for a plurality of morphological features based on the patches, and calculating a distant metastatic recurrence probability based on the values. A computer-implemented method of training a neural network and a system for characterizing a cancer in a subject are also described.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating a subject by administering a treatment to a subject identified as having a high probability of distant metastatic recurrence, wherein the probability of distant metastatic recurrence was determined by a process, comprising: acquiring at least one image of a tissue sample comprising a plurality of cells, taken from a subject; classifying each of the plurality of cells into categories; dividing the at least one image into a plurality of patches, each patch comprising multiple cells of the plurality of cells; assigning cells in each of the plurality of patches to one or more clusters using a clustering algorithm to produce clustering data for each patch, the clustering data comprising a cluster size; calculating a cell density of each of the plurality of patches; calculating values for a plurality of morphological features based on the patches; and calculating a distant metastatic recurrence probability based on the values, the cell density, and the clustering data. 2. The method of claim 1 , wherein the patches are acquired at least in part by random sampling. 3. The method of claim 1 , wherein the categories comprise tumor cells, non-tumor cells, or immune cells. 4. The method of claim 1 , further comprising identifying a subset of the patches of the image meeting a criterion selected from the group consisting of no cells appearing in the patch and no tumor cells appearing in the patch; and discarding the subset of patches. 5. The method of claim 1 , wherein the distant metastatic recurrence probability is calculated by at least one neural network. 6. The method of claim 1 , wherein the patches are selected by calculating a cell density and comparing the cell density to a threshold. 7. The method of claim 1 , wherein the morphological features comprise at least one of (Count of immune cells in “large” cluster)/(Total count of immune cells); (Count of immune cells in “large” cluster)/(Total count of tumor+immune); (Count of immune cells in “large” cluster)/(Count of tumor cells in “large” cluster); (Count of immune cells in “large” cluster)/(Count of immune cells in “small” cluster); (Total count of immune cells)/(Total count of tumor+immune); (Immune cell total area)/(Tumor cell total area); and (Immune cell total area)/(Total Immune area+Tumor area). 8. The method of claim 1 , wherein the distant metastatic recurrence probability is calculated by aggregating a set of votes for each patch in the plurality of patches based on the values. 9. The method of claim 1 , wherein the at least one image comprises at least first and second images, the first and second images acquired from different body regions of the subject. 10. The method of claim 1 , wherein the treatment is selected from the group consisting of Nivolumab, Perbrolizumab, Ipilimumab, Dabrafenib, Trametinib, Vermurafenib, high-dose interferon alfa, chemotherapy, surgical excision, and immunotherapy.

Assignees

Inventors

Classifications

  • characterised by memory or gating, e.g. long short-term memory [LSTM] or gated recurrent units [GRU] · CPC title

  • Convolutional networks [CNN, ConvNet] · CPC title

  • Supervised learning · CPC title

  • Matching; Classification · CPC title

  • using classification, e.g. of video objects · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12019674B2 cover?
A method of treating a subject comprises administering a treatment to a subject identified as having a high probability of distant metastatic recurrence, wherein the probability of distant metastatic recurrence was determined by a process, comprising acquiring at least one image of a tissue sample comprising a plurality of cells, taken from a subject, classifying each of the plurality of cells …
Who is the assignee on this patent?
Univ New York
What technology area does this patent fall under?
Primary CPC classification G06F16/55. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).